Jul 8, 2026 05:08PM

Jul 1, 2026 06:58AM

Jun 30, 2026 11:00AM

Jun 30, 2026 08:30AM

Jun 18, 2026 06:11AM

May 6, 2026 04:46PM

Apr 17, 2026 06:46AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)

Mar 27, 2026 07:00PM

Mar 26, 2026 06:39AM

Mar 25, 2026 04:04PM

Mar 25, 2026 03:05PM

Mar 25, 2026 03:02PM

Mar 25, 2026 10:46AM

Mar 25, 2026 10:43AM Wolfe Research stays Peerperform on Sarepta Therapeutics (SRPT) as data boosts RNA-focused narrative

Mar 25, 2026 10:33AM

Mar 25, 2026 10:32AM

Mar 25, 2026 08:05AM

Mar 19, 2026 11:11AM

Mar 19, 2026 10:57AM

Mar 19, 2026 08:30AM

Mar 17, 2026 07:37AM Cantor Fitzgerald Reiterates Neutral Rating on Sarepta Therapeutics (SRPT)

Mar 16, 2026 08:34AM

Mar 12, 2026 05:06PM

Mar 9, 2026 03:22PM

Mar 3, 2026 03:44PM

Mar 3, 2026 12:00PM

Mar 2, 2026 06:47AM

Feb 26, 2026 08:30AM Sarepta to present Duchenne muscular dystrophy data at 2026 MDA conference

Feb 25, 2026 04:45PM

Feb 24, 2026 09:08AM

Feb 4, 2026 08:30AM

Jan 27, 2026 06:43AM

Jan 26, 2026 12:54PM

Jan 26, 2026 08:01AM

Jan 26, 2026 05:30AM Sarepta Therapeutics (SRPT) call put ratio 1.7 calls to 1 put into presenting three-year results from its EMBARK study of ELEVIDYS

Jan 26, 2026 05:18AM

Jan 23, 2026 04:05PM

Jan 14, 2026 06:55AM

Jan 14, 2026 04:39AM

Jan 12, 2026 11:59AM

Jan 12, 2026 09:30AM

Jan 8, 2026 03:59AM Leerink Partners Reiterates Market Perform Rating on Sarepta Therapeutics (SRPT)

Jan 7, 2026 08:31AM

Dec 11, 2025 11:53AM

Dec 9, 2025 06:50AM

Nov 25, 2025 08:58AM

Nov 25, 2025 07:31AM

Nov 24, 2025 07:31AM

Nov 24, 2025 07:30AM Arrowhead Pharmaceuticals receives $200 million from Sarepta milestone

Nov 20, 2025 03:59AM

428,612 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All